Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a prominent player in the biopharmaceutical industry, focused on the research, development, manufacturing, and marketing of a comprehensive range of medica... Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a prominent player in the biopharmaceutical industry, focused on the research, development, manufacturing, and marketing of a comprehensive range of medication products. As a major Chinese pharmaceutical enterprise, Jiangsu Hengrui Pharmaceuticals excels in oncology, anesthesia, imaging, and contrast agents, making significant strides in these therapeutic areas. The company is recognized for its dedication to innovation, with an extensive portfolio ranging from antineoplastic drugs to modern medicinal therapies. Headquartered in Lianyungang, Jiangsu Province, the company serves diverse healthcare needs both domestically and internationally. It plays a crucial role in advancing public health by providing accessible and innovative pharmaceutical solutions. Given its strategic partnerships and robust pipeline development, Jiangsu Hengrui Pharmaceuticals is considered a vital contributor to the pharmaceutical landscape, catering primarily to the growing demands of the healthcare sector in China and progressively expanding its influence globally.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Jiangsu Hengrui Pharmaceuticals

We reviewed Jiangsu Hengrui Pharmaceuticals's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Jiangsu Hengrui Pharmaceuticals's data?

Start your 30-day free trial to request a data review for Jiangsu Hengrui Pharmaceuticals.

Start Free Trial

Legal Center Contact Us